Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Ovoca Bio Plc (OVB) Euro 0.125

Sell:9.50p Buy:10.30p 0 Change: No change
Market closed Prices as at close on 11 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.50p
Buy:10.30p
Change: No change
Market closed Prices as at close on 11 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.50p
Buy:10.30p
Change: No change
Market closed Prices as at close on 11 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ovoca Bio plc (Ovoca) is an Ireland-based biopharmaceutical company. The Company is focused on identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD).

Contact details

Address:
Dublin 2, 17 Pembroke Street Upper
DUBLIN
2
Ireland
Telephone:
+353 (01) 6619819
Website:
https://ovocabio.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 16 September 2019 16/09/19
AGM 08 August 2019 08/08/19
Final results 28 June 2019 28/06/19
Annual report 28 June 2019 28/06/19

General stock information

EPIC:
OVB
ISIN:
IE00B4XVDC01
Market cap:
£8.07 million
Shares in issue:
81.56 million
Sector:
Mining
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Mikhail Mogutov
    Executive Chairman of the Board
  • Kirill Golovanov
    Chief Executive Officer, Executive Director, Corporate Secretary
  • Svetlana Radchenko
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.